Observe Medical ASA (OSL:OBSRV)

Norway · Delayed Price · Currency is NOK

0.9740

-0.0260 (-2.60%)

At close: Aug 4, 2026

Observe Medical ASA Financials Overview

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	23.94	18.81	18.48	27.94	19.52	24.04
Revenue Growth	220.31%	1.77%	-33.85%	43.14%	-18.80%	711.96%
Gross Profit	4.7	4.7	1.82	9.29	5.18	9.52
Operating Income	-79.07	-79.07	-47.07	-124.21	-59.14	-36.54
Net Income	-48.64	-48.64	-58.73	-135.1	-50.8	-26.32
Earnings Per Share	-0.73	-0.73	-3.95	-2.34	-16.19	-20.09
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Europe	16.14	16.14	15.52
Asia	2.13	2.13	1.51
Americas	0.54	0.54	0.2
Total	18.81	18.81	17.23

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	11.5	11.5	1.98	13.68	13.64	2.86
Total Debt	30.74	30.74	83.37	55.92	45.75	55.07
Net Cash (Debt)	-19.24	-19.24	-81.39	-42.25	-32.11	-52.21
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.29	-0.29	-5.47	-13.42	-10.20	-39.92

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-24.83	-24.83	-27.43	-24.45	-51.33	-22.13
Capital Expenditures	-1.14	-1.14	-1.84	-8.02	-4.93	-4.89
Free Cash Flow	-25.97	-25.97	-29.27	-32.47	-56.26	-27.01
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	19.63%	24.99%	9.85%	33.24%	26.52%	39.59%
Operating Margin	-330.26%	-420.31%	-254.67%	-444.52%	-302.97%	-152.00%
Pretax Margin	-203.17%	-258.57%	-317.72%	-483.44%	-259.85%	-109.48%
Profit Margin	-203.17%	-258.57%	-317.72%	-483.50%	-260.24%	-109.48%
FCF Margin	-108.49%	-138.07%	-158.37%	-116.21%	-288.21%	-112.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	7.05	5.36	84.12	31.66	5.60	11.00